Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- A Clearer Clinical Picture: Exploring Shifts in Use, Cost of Diagnostic Imaging
-
- Direct-to-consumer Ads and the Rheumatologist: Time for Value-based Care Approach Leonard H. Calabrese, DO
- Imagine Dragons Frontman Raises Awareness for Ankylosing Spondylitis With ‘Monster Pain in the AS’
- Battle for Enbrel: Ruling on Patent Lawsuit Could Transform US Biosimilar Marketplace
- Black, Latina Women With Knee OA Desire Timelier Information on Therapy Options
- Footwear Intervention Fails to Improve Gout Foot Pain
- Racial, Ethnic Minorities at Greater Risk for Severe Lupus Manifestations
- Rheumatologists, Patients Share Common Barriers to Controlling RA
- Sugar-sweetened Beverages Linked to 208% Increase in Incident Gout
-
- No Link Between TNF Inhibitors, Increased Risk for Cancer in PsA
- IgG4 Role Overplayed in the Inflammatory ‘Symphony’ of IgG4-related Disease
- Partial Knee Replacement Increases Risk for Long-term Revision
- Tapering Glucocorticoids Effective in Two-thirds of Tocilizumab-treated Patients With RA
- More than Half of Patients With Arthritis Report CBD Use
- Ixekizumab Bests Adalimumab in PsA in Head-to-head Comparison
- Rosacea, Other ‘Mimic’ Skin Conditions Often Misdiagnosed as Rheumatic Diseases
- All the President's Secrets: John F. Kennedy and Addison's Disease
-
- Speaking the Language: Health Care Execs Join United Rheumatology to Advocate for Independent Practice
- Abatacept has Highest Overall Retention Rate Among Seven Biologics for RA
- ACR: Proposed Legislation Could Eliminate Prior Authorization ‘Hurdles’ in Medicare Advantage
- No Impact on Safety, Efficacy in Etanercept-to-biosimilar Switch in RA
- Rheumatologists Vary on When to Discontinue Arthritis Drugs During Unplanned Pregnancies